IR-Med (IRME) Stock Statistics & Valuation Metrics

IR-Med has a market cap or net worth of $681.64K. The enterprise value is $727.67K.

IR-Med has 97,377,690 shares outstanding. The number of shares has decreased by -2.65% in one year.

IR-Med’s return on equity (ROE) is 6.46 and return on invested capital (ROIC) is 1416.79%.

The current PE Ratio of IR-Med is ―. IR-Med’s PEG ratio is 0.28.

In the last 12 months, IR-Med had revenue of 0.00 and earned -1.90M in profits. Earnings per share was -0.03.

In the last 12 months, operating cash flow was -837.00K and capital expenditures 0.00, giving a free cash flow of -837.00K billion.

IR-Med pays an annual dividend of ―, resulting in a dividend yield of ―

IR-Med upcoming earnings date is ―, ―.

IR-Med as a current ratio of 0.38, with Debt / Equity ratio of -40.00%

In the past 12 months, IR-Med has paid 0.00 in taxes.

IR-Med EV to EBITDA ratio is -17.59, with an EV/FCF ratio of -23.79.

IR-Med has $63.00K in cash and marketable securities with $250.00K in debt, giving a net cash position of -$187.00K billion.

Gross margin is 23.08%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for IR-Med is ―, which is 11.43% higher than the current price. The consensus rating is ―